| Literature DB >> 32218703 |
Ju-Young Lee1,2, Faiz Ur Rahman1, Eun-Kyeung Kim1, Sang-Mi Cho1, Hae-Rim Kim1, Kihoon Lee1, Chin-Soo Lee1, Won-Kee Yoon1, Ok-Sung Moon1, Young-Won Seo1, Young-Suk Won1, Hyoung-Chin Kim1, Bae-Hwan Kim2, Ki-Hoan Nam1.
Abstract
Importin-11 (Ipo11) is a novel member of the human importin family of transport receptors (karyopherins), which are known to mediate the nucleocytoplasmic transport of protein and RNA cargos. Despite its role in the transport of protein, we found that knockout of Ipo11 nuclear import factor affects normal embryonic development and govern embryo-lethal phenotypes in mice. In this study, we for the first time produced a mouse line containing null mutation in Ipo11 gene utilized by gene trapping. The Ipo11-/- embryos showed an embryonic lethal phenotype. The Ipo11-/- embryos showed a reduced size at embryonic day 10.5 (E10.5) when compared with Ipo11+/+ or Ipo11+/- embryos and died by E11.5. Whereas Ipo11+/- mice were healthy and fertile, and there was no detectable changes in embryonic lethality and phenotype when reviewed. In the X-gal staining with the Ipo11-/- or Ipo11+/- embryos, strong X-gal staining positivity was detected systematically in the whole mount embryos at E10.5, although almost no X-gal positivity was detected at E9.5, indicating that the embryos die soon after the process of Ipo11 expression started. These results indicate that Ipo11 is essential for the normal embryonic development in mice. © The author(s).Entities:
Keywords: Importin-11; embryonic development; embryonic lethal; knockout; null mutation; phenotype
Mesh:
Substances:
Year: 2020 PMID: 32218703 PMCID: PMC7085267 DOI: 10.7150/ijms.40697
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Figure 1Generation of Ipo11 mutant mice. (A) This figure represents the schematic representation of the genomic organization of the murine Ipo11 gene and the insertional mutation resulting from gene-trapping with the pU-21T vector. The locations of the pU-21T vector was inserted gene between exon 2 and exon 3 of the Ipo11 gene comprising 30 exons. The E, exon; SA, splicing acceptor; β-geo, beta-galactosidase and neomycin; pA, polyadenylation site. (B) The PCR genotyping analysis to distinguish wild-type allele (514bp) and mutant allele (322bp). PCR primers presented W-F1, W-R1 and M-R1 in Fig 1A. (C) Reverse-transcriptase PCR analysis of whole Ipo11+/+, Ipo11+/- and Ipo11-/- E10.5 embryos from exons 22 to 30 clearly demonstrates the loss of the homozygous mutant samples. The RT-PCR primers presented RT-F and RT-R. The PCR reactions were multiplexed with β-actin (lower band) to assess quality of the RNA and cDNA samples. (D) Western blotting from whole E10.5 embryo lysates with genotypes indicated above each lane. The filter was developed with anti-Ipo11 and anti-GAPDH antibody as loading control. +/+, +/-, and -/- indicate Ipo11+/+, Ipo11+/-, and Ipo11-/- genotypes, respectively. The body weights for male (E) and female (F) Ipo11 heterozygous mice were measured every week from 4 to 16 weeks of age. n=8 for each group.
Genotype analysis of Ipo11 intercross progeny
| Stage | Genotype | ND | p-value* | Total | ||
|---|---|---|---|---|---|---|
| +/+ | +/- | -/- | ||||
| 4 weeks | 82 | 154 | 0 | - | 0.000 | 236 |
| E18.5 | 2 | 6 | 0 | 0 | 0.504 | 8 |
| E15.5 | 3 | 10 | 0 | 2 | 0.187 | 16 |
| E12.5 | 2 | 8 | 0 | 4 | 0.406 | 14 |
| E11.5 | 7 | 16 | 0 | 5 | 0.037 | 28 |
| E10.5 | 18 | 28 | 16 | 4 | 0.872 | 66 |
| E9.5 | 6 | 13 | 5 | 2 | 1.000 | 26 |
| E8.5 | 2 | 5 | 4 | 0 | 0.880 | 11 |
E, day of the embryonic development. ND, not determined. *, Chi-square test or Fisher's exact test were performed for goodness of fit to the expected Mendelian ratios 1:2:1.
Figure 2Abnormal growth and embryonic lethality of This represents the whole mount embryos at different stages of development, E 9.5, E 10.5 and E 11.5, as derived from intercrosses of Ipo11mice. (A-D) Bright-field images of Ipo11(left) and Ipo11(right) embryos; embryos at E 10.5 embryos within yolk sacs (B), E10.5 embryos with yolk sacs removed (C), and E11.5 embryos (D), respectively.
Figure 3Expression of Ipo11 during mouse development. This represents the whole mount lateral views (left panels) and sections (right panels) of Ipo11 embryos at E9.5 (A) and E10.5 (B) stained with X-gal. Ipo11-β-gal expression is specific for the homozygotes and the wild-type embryos do not show any staining for β-galactosidase. The genotypes of the WT and homozygotes were determined using the yolk sacs of the embryos. ht, heart; nt, neural tube; fl, forelimb; hl, hindlimb.
Figure 4Immunohistochemical staining of Tissues from Ipo11 heterozygous (+/-) adult mice aged 8 weeks were screened for their Ipo11 gene expressions by the use of the process of immunohistochemical staining with anti-β-galactosidase antibody. In this case, age matched wild-type (+/+) mice were used as a negative control. In the figure, (A and B), represent the Testis, and (C and D), represent the Pancreas. The size bars represent 200 µm.